Asarfi Hospital Stock Hits New 52-Week High at Rs.193.8

Nov 18 2025 12:10 PM IST
share
Share Via
Asarfi Hospital has reached a significant milestone by hitting a new 52-week high of Rs.193.8, marking a notable achievement in its stock performance. This peak reflects the stock's strong momentum over the past year, supported by robust financial metrics and consistent quarterly results.



Today’s trading saw Asarfi Hospital’s stock price touch Rs.193.8, setting both a new 52-week and all-time high. Despite a day change of -1.65%, the stock remains well above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained upward momentum. The recent price action follows two consecutive days of gains before a slight pullback, suggesting a phase of consolidation after the rally.



Over the last year, Asarfi Hospital’s stock has delivered a remarkable return of 122.42%, significantly outperforming the Sensex’s 9.72% return during the same period. This outperformance highlights the stock’s strong relative strength within the hospital sector and the broader market. The 52-week low for the stock was Rs.72.9, underscoring the substantial appreciation in value over the past twelve months.




Turnaround taking shape! This micro-cap from Hospital sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!



  • Recently turned profitable

  • Strong business fundamentals

  • Pre-breakout opportunity


Catch the Breakout Early →




Financially, Asarfi Hospital has demonstrated solid performance in recent quarters. The company reported its highest quarterly net sales at Rs.44.89 crores, accompanied by a peak PBDIT of Rs.8.87 crores and a PBT less other income of Rs.4.89 crores. These figures reflect a positive trend in operational results, with net profit growth of 34.38% noted in the latest quarter ending September 2025. The company has declared positive results for two consecutive quarters, reinforcing the consistency in its earnings trajectory.



From a valuation standpoint, Asarfi Hospital presents an enterprise value to capital employed ratio of 3.3, which is considered attractive within the hospital sector. The return on capital employed (ROCE) stands at 8.6%, indicating the company’s ability to generate returns on its invested capital, albeit at a moderate level. The company’s debt servicing capacity is supported by a low Debt to EBITDA ratio of 1.44 times, suggesting manageable leverage and financial stability.



Market conditions today saw the Sensex open 91.42 points higher but subsequently decline by 188.77 points, trading at 84,853.60, which is 0.11% lower on the day. The Sensex remains close to its own 52-week high of 85,290.06, currently just 0.51% away. The index is trading above its 50-day moving average, with the 50 DMA positioned above the 200 DMA, signalling a generally bullish trend in the broader market environment.




Want to dive deeper on Asarfi Hospital ? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!



  • Real-time research report

  • Complete fundamental analysis

  • Peer comparison included


Read the Full Verdict →




Despite the strong price performance, some metrics indicate areas of caution. The company’s average ROCE of 8.67% suggests moderate profitability per unit of capital employed. Additionally, operating profit has grown at an annual rate of 14.76% over the last five years, reflecting a steady but not rapid expansion in core earnings. Institutional investor participation has declined slightly, with a reduction of 1.04% in their stake over the previous quarter, collectively holding 2.24% of the company’s shares. This shift may reflect changing portfolio allocations among institutional holders.



Asarfi Hospital’s stock price momentum and financial data together illustrate a company that has achieved a significant milestone in its market valuation. The new 52-week high of Rs.193.8 is a testament to the stock’s strong performance relative to its sector and the broader market. While the stock underperformed its sector by 0.49% on the day of the new high, its overall trend remains positive, supported by consistent quarterly results and sound financial ratios.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News